Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)
Apply
DRP-104 & Durvalumab
DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step